Different Ultrafiltration Rates and Intradialytic Hypotension.

February 10, 2026 updated by: Marwa Mahmoud Gad, Sohag University

Association of Ultrafiltration Rates and Intradialytic Hypotension in Sohag University Hospitals.

Finding relationship between different ultrafiltration rates and intradialytic hypotension in attempt to find the optimal cut off points.

Study Overview

Status

Completed

Conditions

Detailed Description

This observational study will be carried upon hemodialysis patients with different ultrafiltration rates at each session to study the association between ultrafiltration rates and intradialytic hypotension.

Thus identifying the optimal cut off of ultrafiltration rate points for each patient

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Sohag, Egypt
        • Sohag University Hospitals,Faculty of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Hemodialysis patients more than 18 year old on maintenance hemodialysis receiving 3 sessions weekly.

Description

Inclusion Criteria:

All patients aged 18 Year or older on maintenance haemodialysis for at least 3 consecutive months receiving 3 sessions weekly.

-

Exclusion Criteria:

Patients aged < 18 years old.

Patients on recent haemodialysis < 3 months.

Pregnant women.

Patients with malignancy, severe infections or sepsis.

Patients with major bleeding.

Patients who cannot go upper limb monitoring of blood pressure.

Patients with severe heart failure (NYHA) class 3 or more.

Patients with severe anemia, Hemoglobin less than 6 g/dl.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevent Intradialytic Hypotension
Time Frame: 6 month
Finding the optimal threshold of ultrafiltration rates to prevent intradialytic hypotension through observing the risk factors associated with the occurrence of HDH
6 month
Clinical History Among the Study Patients.
Time Frame: 6 months
Analysis of the prevalence of chronic illness among the study participants, as well as the number of antihypertensive drugs used.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2025

Primary Completion (Actual)

December 1, 2025

Study Completion (Actual)

January 1, 2026

Study Registration Dates

First Submitted

November 15, 2024

First Submitted That Met QC Criteria

November 15, 2024

First Posted (Actual)

November 19, 2024

Study Record Updates

Last Update Posted (Actual)

March 2, 2026

Last Update Submitted That Met QC Criteria

February 10, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med--24-11-12MS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe